Deep, targeted future-generation sequencing has revealed that subclonal mutations (i.e., All those existing in only a fraction of tumor cells) might be detected for all driver genes and they are connected with swift sickness development and weak outcome.11–thirteen This is particularly related for TP53 mutations offered the fact that, as defined